749
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Prevalence and Determinants of Hypertension Among Diabetic Patients in Jimma University Medical Center, Southwest Ethiopia, 2019

ORCID Icon & ORCID Icon
Pages 2317-2325 | Published online: 01 Jul 2020

References

  • WHO A. Global Brief on Hypertension. Silent killer, global public health crisis; 2013.
  • Kotchen TA. Hypertension control: trends, approaches, and goals. Hypertension. 2007;49(1):19–20. doi:10.1161/01.HYP.0000250394.05703.06
  • Lopez-Jaramillo P, Lopez-Lopez J, Lopez-Lopez C, Rodriguez-Alvarez MI. The goal of blood pressure in the hypertensive patient with diabetes is defined: now the challenge is go from recommendations to practice. Diabetol Metab Syndr. 2014;6(1):31. doi:10.1186/1758-5996-6-31
  • Paul B, Sapra B, Maheshwari S, Goyal R. Role of losartan therapy in the management of diabetic hypertension. J Assoc Physicians India. 2000;48(5):514–518.
  • Mendis S. Challenges for the management of hypertension in low-resource settings. Ethn Dis. 2003;13(2 Suppl 2):S67– 70.
  • Kahya NE, Harman E, Dolek D, et al. Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension. Turk Kardiyol Dern Ars. 2014;42(8):7.
  • Geneva W. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
  • World Health Organization. Regional Office for Southeast Asia. Hypertension fact sheet.
  • Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28(11):2668–2686. doi:10.2337/diacare.28.11.2668
  • Aroda VR, Knowler WC, Crandall JP, et al. Metformin for diabetes prevention: insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia. 2017;60(9):1601–1611. doi:10.1007/s00125-017-4361-9
  • WHO. A Global Brief on Hypertension. World Health Organization Press; 2013.
  • Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2015;313(6):603–615. doi:10.1001/jama.2014.18574
  • Prospective Diabetes Study Group UK, United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317,(7160):703–713. doi:10.1136/bmj.317.7160.703
  • Alwan A. Global Status Report on Noncommunicable Diseases 2010. World Health Organization; 2011.
  • Koly KN, Biswas T, Islam A. Increasing prevalence of hypertension in Bangladesh: a review. Cardiovasc J. 2015;8(1):59–64. doi:10.3329/cardio.v8i1.24771
  • Hendriks ME, Wit FWNM, Roos MTL, et al. Hypertension in sub- Saharan Africa: cross-sectional surveys in four rural and urban communities. PLoS One. 2012;7(3):e32638. doi:10.1371/journal.pone.0032638
  • Riley L, Guthold R, Cowan M, et al. The World Health Organization STEPwise approach to non-communicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health. 2016;106(1):74–78. doi:10.2105/AJPH.2015.302962
  • Jansson SP, Svärdsudd K, Andersson DK. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years’ follow‐up. Diabetic Med. 2014;31(9):1055–1063. doi:10.1111/dme.12514
  • Arshad AR. Control of blood pressure in hypertensive patients with diabetes mellitus type 2. Pak Hear J. 2014;47(02):78–83.
  • Al-mahroos F, Al-roomi K, Mckeigue PM. Relation of high blood pressure to glucose intolerance, plasma lipids and educational status in an Arabian Gulf population. Int J Epidemiol. 2000;29(1):71–76. doi:10.1093/ije/29.1.71
  • Tseng CH. Higher risk of hypertension in indigenous type 2 diabetic patients in Taiwan. J Hypertens. 2006;24(9):1817–1821. doi:10.1097/01.hjh.0000242406.76085.c4
  • Chuhwak EK, Puepet FH, Okeahialam BN, Ohwovoriole AE. Hypertension and Diabetes in Jos, Nigeria. Diabetes Int. 2002;12:25–26.
  • Mengesha AY. Hypertension and related risk factors in type 2 diabetes mellitus (DM) patients in Gaborone City Council (GCC) clinics, Gaborone. Afr Heal Sci. 2007;7(4):244–245.
  • Nouh F, Omar M, Younis M. Prevalence of Hypertension among Diabetic Patients in Benghazi: A Study of Associated Factors. Asian J Med Heal. 2017;6(4):1–11. doi:10.9734/AJMAH/2017/35830
  • Berraho M, Youness E. Achhab, Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study) Mohamed. Pan Afr Med J. 2012;11.
  • Alqudah BM, Mahmoud H, Alhusamia S, Sh A, Al L, Alawneh ZE. Prevalence of hypertension among diabetic type 2 patients attending medical clinic at Prince Hashem bin Abdullah Hospital in Aqaba. Indian J Med Res Pharm Sci. 2017;4:(June):47–54.
  • Mansour AA, Prevalence and control of hypertension in Iraqi diabetic patients: a prospective cohort study. Open Cardiovasc Med J. 2012;1:68–71. doi:10.2174/1874192401206010068
  • Giday A, Wolde M, Yihdego D. Hypertension, obesity and central obesity in diabetics and non-diabetics in Southern Ethiopia. Ethiop J Health Dev. 2010;24.
  • Satman I, Yilmaz T. Population-based study of diabetes and risk characteristics in Turkey. Diabetes Care. 2002;25(9):1551–1556. doi:10.2337/diacare.25.9.1551
  • Venugopal K, Mohammed MZ. Prevalence of hypertension in type-2 diabetes mellitus. J Heal Res. 2014;1:4.
  • Satman I, Omer B, Tutuncu Y. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169–180. doi:10.1007/s10654-013-9771-5
  • Colosia AD, Roberto P, Shahnaz K. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: A systematic literature review. Diabetes Metab Syndr Obes. 2013;6(1):327–338. doi:10.2147/DMSO.S51325
  • Csige I, Ujvárosy D, Szabó Z, et al. The impact of obesity on the cardiovascular system. J Diabetes Res. 2018;2018.
  • Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000;8(9):605–619. doi:10.1038/oby.2000.79
  • Velásquez-Rodríguez CM, Velásquez-Villa M, Gómez-Ocampo L, Bermúdez-Cardona J. Abdominal obesity and low physical activity are associated with insulin resistance in overweight adolescents: a cross-sectional study. BMC Pediatr. 2014;14(1):258. doi:10.1186/1471-2431-14-258
  • Al-Habori M. The potential adverse effects of habitual use of Catha edulis (khat). Expert Opin Drug Saf. 2005;4(6):1145–1154. doi:10.1517/14740338.4.6.1145
  • Hassan NA, Gunaid AA, Murray-Lyon IM. Khat (Catha edulis): health aspects of Khat chewing. East Mediterr Health J. 2007;13(3):706–718.
  • Getahun W, Gedif T, Tesfaye F. Regular Khat (Catha edulis) chewing is associated with elevated diastolic blood pressure among adults in Butajira, Ethiopia: A comparative study. BMC Public Heal. 2010;10:4–11.
  • Toennes SW, Harder S, Scharmm M, Niess C, Kauert GF. Pharmacokinetics of Cathinone and norephedrine after the chewing of Khat leaves. Br J Clin Pharmacol. 2003;56(1):125–130. doi:10.1046/j.1365-2125.2003.01834.x
  • Hassan NA, Gunaid AA, Abdo-Rabbo AA, Abdel-Kader ZY. The effect of Qat chewing on blood pressure and heart rate in healthy volunteers. Trop Doct. 2000;30(2):107–108. doi:10.1177/004947550003000219